Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More
2 minute read

LuxUrban Hotels And Company’s Chairman And Co-CEO Mutually Agree To Cancel $10M Financing Arrangement In Light Of Ongoing Discussions To Enhance Access To Non-Dilutive Capital

By Benzinga Newsdesk
December 4, 9:07 AM
Chairman and Co-CEO has Ceased Further Sales of the Company's Common Stock Associated with the Now Cancelled Financing ArrangementLuxUrban Hotels Inc. (or the "Company") (NASDAQ:LUXH), which utilizes an asset-light

LUXH

Read More
3 minute read

Cybin’s Novel Psilocybin Topline Data: 79% Remission In Major Depression Symptoms, What’s Next?

By Lara Goldstein
December 3, 9:42 PM
Next-generation psychedelics biotech Cybin Inc. (NYSE: CYBN) released the full Phase 2 trial results of its deuterated psilocybin derivative CYB003 for Major Depressive Disorder (MDD.) Although a relatively small trial, outcomes for the novel psychedelic are so far showing st

CYBN

Read More
2 minute read

Blackwells Capital Says “Disney Has One Of The Most Attractive Portfolios Of Beloved Brands And Businesses”; Peltz And Trian “Need To Withdraw This Costly And Disruptive Effort To Displace Experienced Voices” In Disney Boardroom

By Benzinga Newsdesk
November 30, 5:31 PM
Blackwells Capital LLC, a shareholder of The Walt Disney Company ("Disney" or the "Company") (NYSE: DIS) since 2018, today issued its support for the ongoing transformative restructuring led by the Company's CEO Bob Iger, and stewarded by an enviable Board of Directors recently enhanced through the appointments of James P.

DIS